Search results
Study uncovers at least one cause of roadblocks to cancer immunotherapy
Medical Xpress· 4 hours agoT cells—the body's foot soldiers against invaders, ranging from everyday infections to cancers—are...
Researchers find B cells drive responses of other immune cells, can be modified to prevent multiple...
Medical Xpress· 7 hours agoIn individuals with multiple sclerosis (MS), abnormally active respiration in B cells drives pro-inflammatory responses of myeloid cells and T cells, leading them to attack the protective sheath ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 hours agoTC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell ...
Revolutionizing Cancer Treatment: Key to Prolonging CAR T Cell Life Uncovered
SciTechDaily· 7 days agoFOXO1 is required for T cell memory and is linked to longer-lasting clinical outcomes in CAR T cell...
Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies
Science Daily· 4 days agoThe T cells of the immune system are the main players in the defense against viral infections and tumor cells. The body must therefore keep a tight control on T cell ...
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 hours agoThis data showed encouraging [Inaudible] survival in certain patients with immunogenic response to the vaccine, demonstrating the promise of our vaccine...
Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach - Leukemia
Nature· 7 days agoChimeric antigen receptor (CAR) T-cells have recently been demonstrated to be highly effective in the disease, but the survival curves are yet to plateau. Thus, on-target, off-tumour toxicity ...
Why Is TC Biopharm (TCBP) Stock Up 51% Today?
InvestorPlace· 6 hours agoTC BioPharm (NASDAQ:TCBP) stock is rocketing higher on Monday after the clinical-stage biopharmaceutical company announced a major deal to acquire...
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 5 days agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T cells can ...
Replay wins IND clearance for PRAME T cell cancer therapy
Clinical Trials Arena via Yahoo Finance· 5 days agoGenome writing company Replay Bio has had its investigational new drug (IND) application cleared by...